Partnering & licensing

Partnering to make drug development designable
Interested to learn more about partnering and licensing opportunities?



Partner with us
Platform
We collaborate with leading pharmaceutical companies to embed our AI-driven, wet-lab-integrated platform across their discovery pipelines. These partnerships enable partners to design biologics — from antibodies to multispecifics to other custom biologics — with drug-like properties from the start, expanding the range of targets, formats, and modalities that can be addressed.
Licensing
Nabla also develops a growing portfolio of designed biologics against high-value disease targets. We license these molecules to partners with deep development expertise to accelerate their path to patients and maximize clinical impact.